Alerta Epidemiológica: Uso indebido de medicamentos agonistas del receptor GLP-1 y sus consideraciones para la Región de las Américas

Stakeholder Perceptions on Innovative Private Pharmacy Distribution Channels and Implications for Medicine Quality in Zambia: A Qualitative Study

Systematic Pharmacovigilance and Genetic Validation of Medications Associated With Organizing Pneumonia: Integrating FAERS Data With Multiomics Analysis

Artificial intelligence revolution in toxicology: Clinical precision, global equity, and the 2030 roadmap

INTERGENERATIONAL TRANSMISSION OF SMUGGLING AS A PROFESSION

New Deprescribing Guidance Marks an ‘Important Moment’ in Psychiatry

Alteraciones del metabolismo lipídico inducidas por fármacos: un análisis exploratorio de farmacovigilancia del mundo real basado en el sistema de notificación de eventos adversos de la FDA de EE. UU. (FAERS)

Drug-induced Aseptic Meningitis: Pharmacovigilance Analysis of Japanese Adverse Event Reporting Database

Prescription Monitoring Program Review Among Patients with Cancer Receiving Opioids at a Safety-Net Palliative Medicine Clinic

Comparative pharmacovigilance analysis of suicidality-related adverse events among GLP-1 and non-GLP-1 anti-obesity drugs in the FDA Adverse Event Reporting System

Medical Cannabis Use in France: An Observational Safety Study Based on the RECANN Registry and the Pharmacovigilance/Addictovigilance System From 2021 to 2024

Automated dispensing cabinets and nurse-related medication errors in inpatient settings: A systematic review

MHRA Warns of Rare Severe Pancreatitis With GLP-1 Drugs

Toward Integrative Predictive Toxicology: Advanced Methods for Drug Toxicity and Safety Prediction

FDA Regulatory Failures in Enforcing Limits on GLP-1 Compounding Puts Patients at Risk

Drug-induced upper gastrointestinal bleeding: A real-world pharmacovigilance study

A Pharmacist Consultant Service for Deprescribing Opioids and Benzodiazepines in Older Adults. A Cluster Randomized Trial

Ellas viven más, pero viven peor: la desigualdad en salud que no se ve

Drug-induced vanishing bile duct syndrome: A real world pharmacovigilance study using the FDA adverse event reporting system

Drug-Induced Cutaneous Reactions: A Clinically Oriented Review for Frontline Physicians

Boletín sobre Seguridad de Medicamentos de Uso Humano. Diciembre de 2025

Applications of artificial intelligence for real-world evidence generation: a protocol for a living scoping review

Fake Mounjaro (tirzepatide) KwikPen 15mg pre-filled pens

UK drug regulator seizes 2,000 doses of illegal weight-loss drugs in latest crackdown

3 354 individuals prosecuted in Europol-coordinated hit against pharmaceutical crime networks

Which Drugs Turn Risky When Temperatures Soar?

Chronic Cough in Patients Taking GLP-1s: What Primary Care Clinicians Should Know

Ballymena man convicted for unlawful possession of weight-loss medicines

Reimagining the regulation of informal pharmaceutical markets: The importance of pragmatic expertise and improvisation in Nigeria

Drug-induced upper gastrointestinal bleeding: A real-world pharmacovigilance study

MHRA Drug Safety Update: Falsified Mounjaro KwikPen 15mg pre-filled pens

Puberty blockers: Controversial trial paused over safety concerns

Redefining polypharmacy: Shifting from drug counts to patient-centered clinical appropriateness

Long‐Term Adherence and Drug Utilisation Patterns Among New Users of Anti‐Hyperlipidemic Monotherapy: Development of a Risk Prediction Model

Cómo la Industria Farmacéutica Influye en la Producción de Evidencias Científicas: Manipulación de Investigaciones y Escritura Fantasma (ghostwriting)

Systematic modeling predicts synergistic and safe drug combinations for parasitic diseases

Prospective Study of Adverse Drug Reactions in Patients with Bipolar Disorder at a tertiary centre